Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Lists LCs, Mass Specs as Class I Devices with FDA

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it has listed certain of its liquid chromatography and mass spectrometers as Class I medical devices with the US Food and Drug Administration.

The instruments that were listed are the company's Infinity Series 1200 LC platforms and 6000 Series mass specs. Class I classification is for devices that pose the least risk to patients and Class I devices are the least regulated under FDA's three classifications.

"The latest generation of liquid chromatography and mass spec systems that Agilent has registered holds tremendous value for the medical community, "Gustavo Salem, vice president and general manager of Agilent's Biological Systems Division, said in a statement. "We're being very methodical in bringing this technology to the clinic, while ensuring that the equipment meets the laboratories' needs."

The two systems are manufactured in facilities that are registered with FDA as medical device establishments, a requirement for manufacturing medical devices, Agilent said, adding that in September the facilities were ISO 13485 certified.

In June, Agilent registered its reagent manufacturing facility in Cedar Creek, Texas with FDA as a medical device establishment. At the time the company said it intended to manufacture diagnostic products.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.